Author: Sebastian Leck

Q&A: the European Commission’s Jean-Eric Paquet and CFI’s Dr. Roseann O’Reilly Runte on research infrastructure after COVID-19

Research Money spoke to Jean-Eric Paquet, the director general of the European Commission’s Research and Innovation directorate, along with Roseann O’Reilly Runte, the president and CEO of the Canada Foundation for Innovation, on how COVID-19 will affect research infrastructure and how those lessons might apply to future crises.

Read More

Will Canada’s new investments in commercialization pay off?

Too often, the products of science and research done within Canada’s borders ends up being sold or commercialized elsewhere. But there’s been a strong effort in the last few months to attempt to reverse the decades-long trend, writes Research Money’s managing editor Sebastian Leck.

Read More

Q&A: Evidence for Democracy’s Rachael Maxwell on Budget 2021 and listening to the science

Rachael Maxwell, the new executive director of Evidence for Democracy (E4D), recently released an analysis of the federal budget, which noted promising investments in sectors like quantum tech and genomics but argued that the country needs a national science strategy. Maxwell spoke to Research Money this week about the federal budget, why relationships are most important in developing evidence-based policies, and how she views her organization’s role in the science ecosystem.

Read More

Life sciences organizations ask Ottawa for national strategy following Sanofi investment

A group of 19 health sciences organizations and associations asked for a “coherent” life sciences strategy and increased collaboration this Monday in an open letter addressed to Prime Minister Justin Trudeau. The letter follows a $415-million federal investment into a partnership with French pharmaceutical manufacturer Sanofi to build an influenza vaccine manufacturing facility in Toronto.

Read More